1.
Combination of Sofosburvir and Daclatsvir in the treatment of Hepatitis C Genotype 2 and Genotype 3. mfm. 2021;32(4). Accessed April 16, 2026. https://medicalforummonthly.com/index.php/mfm/article/view/1915